Medical Equipment
Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024
* Lunit SCOPE IO® demonstrates potential to assess immune phenotype as an AI-powered biomarker for predicting efficacy of Nivolumab plus Chemotherapy in advanced gastric cancer, independent of PD-L1 status SEOUL, South Korea, Sept. 10, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provi...
2024-09-10 21:00
2354
RingConn Showcases Gen 2 Smart Ring at IFA 2024: Revolutionizing Sleep Monitoring with Integrated Sleep Apnea Detection
BERLIN, Sept. 10, 2024 /PRNewswire/ -- RingConn
2024-09-10 15:00
2321
ICP DAS-BMP Reveals Advanced Engineering TPUs at Medtec China 2024
HSINCHU, Sept. 10, 2024 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based medical TPU (thermoplastic polyurethane) manufacturer and supplier, is excited to announce its participation in Medtec China 2024. The 18th edition of this exhibition will be held fromSeptember 25-27, 202...
2024-09-10 09:30
2909
Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing
* Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solution...
2024-09-09 21:00
2089
Neurophet-NTU Singapore, recognized for outstanding joint research
- Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced that Neurophet and NTU (Nanyang Technological Univers...
2024-09-09 21:00
2132
Frost & Sullivan grants the Global Targeted Molecular Fluorescent Tracer R&D Leadership Award to Nanjing Nuoyuan Medical Devices Co., Ltd.
SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held inShanghai from August 27 to 30, 2024, co-hosted by LeadLeo. Based on research and analysis of the global ...
2024-09-09 20:06
1771
Intelligent Technology Empowers the Future of Rehabilitation: Siyi Intelligence (Syrebo) Shines at WRRC 2024
i-CREATe & WRRC 2024 SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Siyi Intelligence (Syrebo) played a prominent role at the International Convention on Rehabilitation Engineering and Assistive Technology (i-CREATe 2024) & the World Rehabilitation Robot Convention 2024 (WRRC 2024), held inShanghai fro...
2024-09-09 17:41
2371
MGI Launches New Nanopore Sequencing Products with Advanced CycloneSEQ Technology
SHENZHEN, China, Sept. 9, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced the global rights to commercialize and distribute the new sequencing products CycloneSEQ-WT02* and CycloneS...
2024-09-09 16:24
1885
A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe
Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck® test in Europe in the months ahead, providing patients and clinicians with a urine test to detect and monitor recurrence of bladder cancer and upper tract urothelial carci...
2024-09-09 15:00
1562
Vieworks Unveils Digital Pathology Scanner LUCEON at ECP 2024
ANYANG-SI, South Korea, Sept. 6, 2024 /PRNewswire/ -- Vieworks, a leading name in bioimaging solutions, is to set a new standard in the digital pathology field with the launch of its high-speed slide scanner LUCEON 510. Vieworks will be making its debut as a digital pathology solution provider at...
2024-09-06 22:00
6551
Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement
FORT MILL, S.C., Sept. 5, 2024 /PRNewswire/ -- Betters Medical Investment
Holdings Limited ("Baird Medical" or the "Company"), a leading microwave
ablation ("MWA") medical device developer and provider inChina, and ExcelFin
Acquisition Corp. ("ExcelFin") (NASDAQ:XFIN
2024-09-06 05:23
3578
A Small Step towards a Big Mission! World's First! UltraDx Received First Clinical Approval of Single-Molecule Analyzer, in China
SHANGHAI, Sept. 5, 2024 /PRNewswire/ -- UltraDx Bio is proud to announce that its flagship product, the UD-X™ Fully Automated Single-Molecule Array Fluorescence Immunoassay Analyzer, has received its first clinical registration approval inChina. This groundbreaking achievement is now officially l...
2024-09-05 20:35
2463
Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study
HANGZHOU, China, Sept. 5, 2024 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus Medtech, 02500.HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies inChina, announced that its in-house developed next-generation balloon-expandable dry-tissue tra...
2024-09-05 16:56
2610
The Vietnam Small Animal Veterinary Association (VSAVA) and South Korea's NEL Animal Medical Foundation have joined forces to strengthen international cooperation in veterinary medicine
HO CHI MINH, Vietnam, Sept. 5, 2024 /PRNewswire/ -- Saigon Ventures Co., Ltd. facilitated the signing of a Memorandum of Understanding (MOU) betweenSouth Korea's NEL Animal Medical Foundation (formerly NEL Animal Medical Center) and the Vietnam Small Animal Veterinary Association (VSAVA) to promo...
2024-09-05 10:00
2665
Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR
* AI-based tumor microenvironment classification utilizing Lunit SCOPE IO® shows promise for guiding treatment decisions in advanced BTC SEOUL, South Korea ,Sept. 3, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, to...
2024-09-03 21:00
2153
Skyline Therapeutics' Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis Pigmentosa
BOSTON and SHANGHAI, Sept. 3, 2024 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven gene therapy company committed to developing unique and novel solutions for rare and severe diseases, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) fo...
2024-09-03 18:00
1652
LifeTech Scientific Corporation Announced 2024 Interim Results: International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%
SHENZHEN, China, Aug. 30, 2024 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "LifeTech", Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiarie...
2024-08-30 20:48
8682
ZEISS innovation paves way to more personalized patient care with cutting-edge AI technology and industry-leading surgical solutions
Showcasing at ESCRS from Sept. 6 to 10, in Barcelona, Spain: REFRACTIVE INDUSTRY MILESTONES: ZEISS extends its global refractive industry momentum with more than 10 million eyes treated with ZEISS SMILE and ZEISS SMILE pro; ZEISS announces first treatment in the CE market for hyperopia with len...
2024-08-29 20:00
2414
Discover the Top 6 Highlights of Medtec 2024 and Explore the Latest Industry Trends
SHANGHAI, Aug. 29, 2024 /PRNewswire/ -- The 18th International Medical Device Design and Manufacturing Technology Exhibition (Medtec 2024) will be held at the Shanghai World Expo Exhibition and Convention Center fromSeptember 25th to 27th. This year's event will cover 42,000+㎡and feature over 1,0...
2024-08-29 17:00
2925
Fosun Int'l: Total Revenue for 1H2024 Reaches RMB97.84 Bn, Industrial Operation Profit Amounts to RMB 3.47 Bn
Powered by Core Strengths, Focus on Core Businesses & Reinforce Organic Growth Momentum 2024 Interim Results Highlights: * Total revenue maintained growth, reaching RMB97.84 billion; * Industrial operation profit maintained growth, reaching RMB3.47 billion; * Continued focus on core busines...
2024-08-28 21:51
3819
Week's Top Stories
Most Reposted
Nine Years of Impact: JULO Disburses USD 1.7 Billion in Digital Financing Across Indonesia
[Picked up by 297 media titles]
2025-12-23 14:23
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 277 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 262 media titles]
2025-12-29 18:53CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 259 media titles]
2025-12-29 09:00
"Nihao China" App Launches as an All-in-One Solution for International Visitors
[Picked up by 253 media titles]
2025-12-24 17:54